In the press

Matthew Read comments on MTE tender in Investment Week

Biotech trusts top performance charts in February

Matthew Read comments on sentiment and MTE’s approach in Robin Amos’ article:

“There are tentative signs that sentiment is improving, and Montanaro’s emphasis on high-quality, profitable businesses should leave it well placed to benefit if the recovery gathers momentum.”

Read the article here